Literature DB >> 21350109

Vulnerable populations and the association between periodontal and chronic kidney disease.

Vanessa Grubbs1, Laura C Plantinga, Deidra C Crews, Kirsten Bibbins-Domingo, Rajiv Saran, Michael Heung, Priti R Patel, Nilka Ríos Burrows, Kristina L Ernst, Neil R Powe.   

Abstract

BACKGROUND AND OBJECTIVES: Recent studies suggest an overall association between chronic kidney disease (CKD) and periodontal disease, but it is unknown whether this association is similar across various subpopulations. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study was a cross-sectional analysis of 2001 to 2004 National Health and Nutrition Examination Survey data. CKD was defined as a urinary albumin-to-creatinine ratio ≥30 mg/g or estimated GFR of 15 to 59 ml/min per 1.73 m(2). Adjusted odds ratios were calculated using multivariable logistic regression with U.S. population-based weighting.
RESULTS: These analyses included 6199 dentate adult participants (aged 21 to 75 years) with periodontal exams. The estimated prevalences of moderate/severe periodontal disease and CKD were 5.3% and 10.6%, respectively. Periodontal disease was associated with >2-fold higher risk of CKD that was moderately attenuated after adjustment for age, gender, race/ethnicity, tobacco use, hypertension, diabetes, educational attainment, poverty index ratio, and dental care use. There were no statistically significant interactions between periodontal disease and race/ethnicity, educational attainment, or poverty status. Less-than-recommended dental care use was associated with periodontal disease and CKD and was increasingly prevalent among nonwhites, lower educational attainment, and lower poverty status.
CONCLUSIONS: The association between periodontal disease and CKD is not significantly different among subgroups. However, because nonwhites, those with a lower educational level, and the poor less frequently report use of recommended dental care, the association between periodontal disease and kidney function over time may become stronger among these groups and warrants further investigation.
© 2011 by the American Society of Nephrology

Entities:  

Mesh:

Year:  2011        PMID: 21350109      PMCID: PMC3069360          DOI: 10.2215/CJN.08270910

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  29 in total

1.  Invasion of human coronary artery cells by periodontal pathogens.

Authors:  B R Dorn; W A Dunn; A Progulske-Fox
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Racial differences in the incidence of treatment for end-stage renal disease.

Authors:  S G Rostand; K A Kirk; E A Rutsky; B A Pate
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

3.  Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?

Authors:  J C Whittle; P K Whelton; A J Seidler; M J Klag
Journal:  Arch Intern Med       Date:  1991-07

4.  Racial factors in the incidence and causation of end-stage renal disease (ESRD).

Authors:  R E Easterling
Journal:  Trans Am Soc Artif Intern Organs       Date:  1977

5.  Chronic kidney disease in the urban poor.

Authors:  Yoshio N Hall; Andy I Choi; Glenn M Chertow; Andrew B Bindman
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-03       Impact factor: 8.237

6.  Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.

Authors:  W McClellan; E Tuttle; A Issa
Journal:  Am J Kidney Dis       Date:  1988-10       Impact factor: 8.860

7.  Racial differences in early-onset renal disease among young adults: the coronary artery risk development in young adults (CARDIA) study.

Authors:  Catherine O Stehman-Breen; Daniel Gillen; Michael Steffes; David R Jacobs; Cora E Lewis; Catarina I Kiefe; David Siscovick
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

8.  Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation.

Authors:  Salomon Amar; Noyan Gokce; Sonia Morgan; Mariana Loukideli; Thomas E Van Dyke; Joseph A Vita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-22       Impact factor: 8.311

9.  Porphyromonas gingivalis induces murine macrophage foam cell formation.

Authors:  Mingshan Qi; Hiroshi Miyakawa; Howard K Kuramitsu
Journal:  Microb Pathog       Date:  2003-12       Impact factor: 3.738

10.  Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.

Authors:  C C Cowie; F K Port; R A Wolfe; P J Savage; P P Moll; V M Hawthorne
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

View more
  26 in total

1.  [A Meta-analysis of the effect of non-surgical periodontal therapy on inflammatory factors in patients with chronic kidney disease and periodontitis].

Authors:  Jing Lai; Yuan-Liang Bai; Yin Bai; Jie Mei; Zhi-Wei Zhang; Wen-Jing Tang; Jiao Huang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-12-01

2.  Periodontal disease in chronic kidney disease and end-stage renal disease patients: a review.

Authors:  Venkatesh K Ariyamuthu; Karl D Nolph; Bruce E Ringdahl
Journal:  Cardiorenal Med       Date:  2013-04       Impact factor: 2.041

3.  Urinary enzymatic markers (N-acetyl-beta-D-glucosaminidase) in assessing the tubulointerstitial compartment in chronic glomerulonephritis related to odontogenic foci.

Authors:  Silvia Velciov; Gheorghe Gluhovschi; Romulus Timar; Cristina Gluhovschi; Ligia Petrica; Flaviu Bob; Gheorghe Bozdog; Marius Pricop; Adrian Gluhovschi; Marioara Cornianu; Elena Potencz; Bogdan Timar; Adriana Kaycsa
Journal:  Wien Klin Wochenschr       Date:  2015-09-16       Impact factor: 1.704

4.  The Kidney and Periodontal Disease (KAPD) study: A pilot randomized controlled trial testing the effect of non-surgical periodontal therapy on chronic kidney disease.

Authors:  Vanessa Grubbs; Faviola Garcia; Bonnie L Jue; Eric Vittinghoff; Mark Ryder; David Lovett; Jacqueline Carrillo; Steven Offenbacher; Peter Ganz; Kirsten Bibbins-Domingo; Neil R Powe
Journal:  Contemp Clin Trials       Date:  2016-12-20       Impact factor: 2.226

5.  Association Between Periodontal Disease and Kidney Function Decline in African Americans: The Jackson Heart Study.

Authors:  Vanessa Grubbs; Eric Vittinghoff; James D Beck; Abhijit V Kshirsagar; Wei Wang; Michael E Griswold; Neil R Powe; Adolfo Correa; Bessie Young
Journal:  J Periodontol       Date:  2015-06-25       Impact factor: 6.993

Review 6.  Chronic kidney disease care in the US safety net.

Authors:  Delphine S Tuot; Vanessa Grubbs
Journal:  Adv Chronic Kidney Dis       Date:  2015-01       Impact factor: 3.620

7.  The association of periodontal disease with kidney function decline: a longitudinal retrospective analysis of the MrOS dental study.

Authors:  Vanessa Grubbs; Eric Vittinghoff; George Taylor; Donna Kritz-Silverstein; Neil Powe; Kirsten Bibbins-Domingo; Areef Ishani; Steven R Cummings
Journal:  Nephrol Dial Transplant       Date:  2015-08-27       Impact factor: 5.992

8.  A randomized controlled trial of intensive periodontal therapy on metabolic and inflammatory markers in patients With ESRD: results of an exploratory study.

Authors:  Meggan M H Wehmeyer; Abhijit V Kshirsagar; Silvana P Barros; James D Beck; Kevin L Moss; John S Preisser; Steven Offenbacher
Journal:  Am J Kidney Dis       Date:  2012-12-20       Impact factor: 8.860

9.  Chronic kidney disease and use of dental services in a United States public healthcare system: a retrospective cohort study.

Authors:  Vanessa Grubbs; Laura C Plantinga; Delphine S Tuot; Neil R Powe
Journal:  BMC Nephrol       Date:  2012-04-02       Impact factor: 2.388

10.  Periodontal disease: a covert source of inflammation in chronic kidney disease patients.

Authors:  Gener Ismail; Horia Traian Dumitriu; Anca Silvia Dumitriu; Fidan Bahtiar Ismail
Journal:  Int J Nephrol       Date:  2013-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.